Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Rebamipide 2% Versus Autologous Serum in the Treatement of the Moderate to Severe Dry Eye Associate With Sjögren Syndrome. Pilot, Crossed, Controled, Randomized And Open Study

NCT03608761 is registered in ClinicalTrials.gov with Hospital Nacional Profesor Alejandro Posadas as lead sponsor.

NCT NCT03608761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03608761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Rebamipide 2% Versus Autologous Serum in the Treatement of the Moderate to Severe Dry Eye Associate With Sjögren Syndrome. Pilot, Crossed, Controled, Randomized And Open Study
Lead sponsor
Hospital Nacional Profesor Alejandro Posadas
Phase
Phase 4
Overall status
Completed
Start date
February 6, 2017
Completion date
July 9, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes, sjögren syndrome